Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: Calcium in the vessels and not the bones?

Calcified Tissue International

Volumn 90, Issue 1, 2012, Pages 22-29

  Vestergaard, Peter ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute myocardial infarction; Alendronate; Angina pectoris; Atherosclerosis; Bisphosphonate; Etidronate; Raloxifene

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ANTIHYPERTENSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CLODRONIC ACID; CLOPIDOGREL; CORTICOSTEROID; DIPYRIDAMOLE; DIURETIC AGENT; ETIDRONIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBANDRONIC ACID; PAMIDRONIC ACID; RALOXIFENE; RISEDRONIC ACID; VITAMIN D; ZOLEDRONIC ACID;

ACUTE HEART INFARCTION; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME;

AGED; ALENDRONATE; ATHEROSCLEROSIS; BONE DENSITY CONSERVATION AGENTS; CALCIUM; COHORT STUDIES; DIPHOSPHONATES; ETIDRONIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OSTEOPOROSIS; RALOXIFENE; RETROSPECTIVE STUDIES;

EID: 84857045192     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9549-2     Document Type: Article

References (32)

1. MJ Bolland PA Barber RN Doughty B Mason A Horne R Ames GD Gamble A Grey IR Reid 2008 Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial BMJ 336 262 266 18198394 10.1136/bmj.39440.525752.BE 1:CAS:528:DC%2BD1cXjtlyru7g%3D (Pubitemid 351251627)
2. MJ Bolland A Avenell JA Baron A Grey GS MacLennan GD Gamble IR Reid 2010 Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis BMJ 341 c3691 20671013 10.1136/bmj.c3691
3. MJ Bolland A Grey A Avenell GD Gamble IR Reid 2011 Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis BMJ 342 d2040 21505219 10.1136/bmj.d2040
4. IR Reid MJ Bolland A Avenell A Grey 2011 Cardiovascular effects of calcium supplementation Osteoporos Int 22 1649 1658 21409434 10.1007/s00198-011-1599-9 1:CAS:528:DC%2BC3MXlvFWitLc%3D
5. World Health Organization (2003) Prevention and management of osteoporosis. WHO technical report series 921. WHO, Geneva
6. Lambrinoudaki I, Armeni E, Georgiopoulos G, Kazani M, Kouskouni E, Creatsa M, Alexandrou A, Fotiou S, Papamichael C, Stamatelopoulos K (2011) Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk. Int J Cardiol [Epub ahead of print]
7. Women's Health Initiative 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321 333 10.1001/jama.288.3.321
8. J Manson J Hsia K Johnson J Rossouw A Assaf N Lasser M Trevisan H Black S Heckbert R Detrano O Strickland N Wong J Crouse E Stein M Cushman 2003 Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 523 534 12904517 10.1056/NEJMoa030808 1:CAS:528:DC%2BD3sXmtFCmsr0%3D (Pubitemid 36951364)
9. Women's Health Initiative Steering Committee 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 1701 1712 10.1001/jama.291.14. 1701 (Pubitemid 38489892)
10. EMEA (2003) EMEA public statement on recent publications regarding hormone replacement therapy. http://www.emea.eu.int/pdfs/human/press/pus/ 3306503en.pdf. Accessed 3 December 2003
11. M Vogt J Cauley L Kuller M Nevitt 1997 Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures J Bone Miner Res 12 283 289 9041062 10.1359/jbmr.1997.12.2.283 1:STN:280:DyaK2s7ptlCksw%3D%3D (Pubitemid 27086311)
12. M Sanada A Taguchi Y Higashi M Tsuda I Kodama M Yoshizumi K Ohama 2004 Forearm endothelial function and bone mineral loss in postmenopausal women Atherosclerosis 176 387 392 15380463 10.1016/j.atherosclerosis.2004.05.021 1:CAS:528:DC%2BD2cXnslGgt7s%3D (Pubitemid 39369530)
13. J Divers TC Register CD Langefeld LE Wagenknecht DW Bowden JJ Carr RC Hightower J Xu KA Hruska BI Freedman 2011 Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes J Bone Miner Res 26 1554 1560 21437982 10.1002/jbmr.389 1:CAS:528:DC%2BC3MXptFWgurc%3D
14. LB Tanko YZ Bagger C Christiansen 2003 Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women Calcif Tissue Int 73 15 20 14506949 10.1007/s00223-002-2070-x 1:CAS:528:DC%2BD3sXmsFGltLg%3D (Pubitemid 37022074)
15. E Barrett-Connor D Grady A Sashegyi P Anderson D Cox K Hoszowski P Rautaharju K Harper 2002 Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (multiple outcomes of raloxifene evaluation) randomized trial JAMA 287 847 857 11851576 10.1001/jama.287.7.847 1:CAS:528:DC%2BD38XhsVGitb8%3D (Pubitemid 34252031)
16. E Barrett-Connor L Mosca P Collins M Geiger D Grady M Kornitzer M McNabb N Wenger 2006 Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women N Engl J Med 355 125 137 16837676 10.1056/NEJMoa062462 1:CAS:528:DC%2BD28Xmsl2ktrs%3D (Pubitemid 44050394)
17. RB Roijers N Debernardi JPM Cleutjens LJ Schurgers PHA Mutsaers GJ van der Vusse 2011 Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries Am J Pathol 178 2879 2887 21531376 10.1016/j.ajpath. 2011.02.004 1:CAS:528:DC%2BC3MXoslOntbc%3D
18. S Adami M Passeri S Ortolani M Broggini L Carratelli I Caruso G Gandolini L Gnessi M Laurenzi A Lombardi, et al. 1995 Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis Bone 17 383 390 8573412 10.1016/S8756-3282(95)00262-6 1:CAS:528:DyaK2MXpslWktrs%3D
19. PJ Meunier E Confavreux I Tupinon C Hardouin PD Delmas R Balena 1997 Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up) J Clin Endocrinol Metab 82 2784 2791 9284696 10.1210/jc.82.9.2784 1:CAS:528:DyaK2sXlvFems70%3D (Pubitemid 27385624)
20. NH Bjarnason S Sarkar T Duong B Mitlak PD Delmas C Christiansen 2001 Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis Osteoporos Int 12 922 930 11808544 10.1007/s001980170020 1:CAS:528:DC%2BD38XkslSkug%3D%3D (Pubitemid 34001005)
21. I Gulhan S Bilgili R Gunaydin S Gulhan C Posaci 2008 The effect of strontium ranelate on serum insulin like growth factor-1 and leptin levels in osteoporotic post-menopausal women: a prospective study Arch Gynecol Obstet 278 437 441 18322691 10.1007/s00404-008-0611-x 1:CAS:528:DC%2BD1cXhtVyisbjN
22. PJ Kostenuik SY Smith J Jolette J Schroeder I Pyrah MS Ominsky 2011 Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody Bone 49 151 161 21457806 10.1016/j.bone.2011.03.769 1:CAS:528:DC%2BC3MXnslSnsL8%3D
23. M Madsen H Balling L Eriksen 1990 The validity of the diagnosis of acute myocardial infarction in 2 registries: the Heart Registry compared to the National Patient Registry [in Danish] Ugeskr Laeger 152 308 314 2301079 1:STN:280:DyaK3c7kt1aisA%3D%3D
24. T Andersen M Madsen J Jørgensen L Mellemkjær J Olsen 1999 The Danish National Hospital Register Dan Med Bull 46 263 268 10421985 1:STN:280:DyaK1MzltVyrtw%3D%3D
25. J Mosbech J Jørgensen M Madsen K Rostgaard K Thornberg T Poulsen 1995 The Danish National Patient Register: evaluation of data quality [in Danish] Ugeskr Laeger 157 3741 3745 7631448 1:STN:280:DyaK2Mzlsl2msA%3D%3D
26. LE Lévesque JA Hanley A Kezouh S Suissa 2010 Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes BMJ 340 b5087 20228141 10.1136/bmj.b5087
27. JR Curtis JC Larson E Delzell MA Brookhart SM Cadarette R Chlebowski S Judd M Safford DH Solomon AZ Lacroix 2011 Placebo adherence, clinical outcomes, and mortality in the Women's Health Initiative randomized hormone therapy trials Med Care 49 427 435 21422960 10.1097/MLR.0b013e318207ed9e
28. P Schuetz B Mueller M Christ-Crain W Dick H Haas 2005 Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases Spinal Cord 43 604 610 15867938 10.1038/sj.sc.3101761 1:STN:280:DC%2BD2MrjtlektQ%3D%3D (Pubitemid 41486868)
29. Haran M, Bhuta T, Lee B (2004) Pharmacological interventions for treating acute heterotopic ossification. Cochrane Database Syst Rev (4): CD003321
30. Fleisch H (ed) (1995) Bisphosphonates in bone disease: from the laboratory to the patient. Parthenon, New York
31. MJ Budoff K Nasir R Katz J Takasu JJ Carr ND Wong M Allison JAC Lima R Detrano RS Blumenthal R Kronmal 2011 Thoracic aortic calcification and coronary heart disease events: the multi-ethnic study of atherosclerosis (MESA) Atherosclerosis 215 196 202 21227418 10.1016/j.atherosclerosis.2010.11.017 1:CAS:528:DC%2BC3MXjsFCqt7s%3D
32. P Vestergaard L Mosekilde 2003 Fracture risk associated with smoking-a meta-analysis J Intern Med 254 572 583 14641798 10.1111/j.1365-2796.2003.01232.x 1:STN:280:DC%2BD3srmvFShtA%3D%3D (Pubitemid 37521854)